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Abstract
In this study, the enzyme-linked immunosorbent assays (ELISA) were modified to detect 3-PBA 
in plasma (including the adducted form) and urine among a large group of consumers and farmers 
in an agricultural area. The samples were collected on the same day in the morning from 100 
consumers (50 females, 50 males) and 100 farmers (50 females, 50 males) in the Fang district, 
Chiang Mai province, northern Thailand. The ELISA was very sensitive having an IC50 value of 
26.7 and 15.3 ng/mL, a limit of quantitation of 5 and 2.5 ng/mL and a limit of detection of 1.08 
and 1.94 ng/mL for plasma and urine, respectively. These methods had low (< 5%) intra- and 
inter-assay coefficients of variation. The extraction technique satisfactorily eliminated the matrix 
effect from samples before ELISA analysis, yielding good recoveries (85.9–99.4% and 87.3–
98.0%, respectively). For the volunteer study, the detection rate for plasma 3-PBA was 24% in 
consumers and 42% in farmers, but the median and range values were similar (median 5.87 
ng/mL, range 5.16–8.44 ng/mL in consumers and 6.27 ng/mL, range 4.29–9.57 ng/mL in farmers). 
The rate of detection in the urine was similar (76% and 69%, in consumers and in farmers), yet the 
median concentration was significantly higher in farmers (8.86 μg/g creatinine in consumers vs 
16.1 μg/g creatinine in farmers) and the range also much wider in farmers (1.62–80.5 μg/g 
creatinine in consumers and 0.80–256.2 μg/g creatinine in farmers). There was no correlation 
between plasma 3-PBA and urinary 3-PBA concentrations in the study presumably because 
plasma 3-PBA is a measure of cumulative exposures while urinary 3-PBA reflects acute 
exposures. In addition, metabolism and excretion of pyrethroids varies by individual. 
Nevertheless, this study demonstrated that these volunteers were exposed to pyrethroids. To our 
knowledge, this is the first report that compared plasma 3-PBA and urinary 3-PBA in a large 
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group of volunteers. The ELISA method provided higher sample throughput with lower cost as 
compared to the instrumental analysis.
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Introduction
The synthetic pyrethroids are derived structurally from the natural pyrethrins that originate 
from the botanical insecticide pyrethrum, an extract obtained from the flowers of 
Chrysanthemum cinerariaefolium. Synthetic pyrethroids including cypermethrin, 
deltamethrin and permethrin are registered for use in the United States and many other parts 
of the world and account for more than $1.5 billion in pesticide sales.[1]
Acute toxicity such as headache, dizziness, nausea, irritation of the skin and nose, and 
paraesthesia can occur when exposed to an overdose of pyrethroids.[2,3] In the case of 
chronic toxicity, the pyrethroid fenvalerate may cause lymph node and splenic damage as 
well as carcinogenesis [4] and pyrethroids have a suppressive effect on the immune 
system.[5] Permethrin has been classified as a potential carcinogen at high concentrations by 
the U.S. EPA.[6,7] Pyrethroids may be considered hormone disruptors from studies on their 
estrogenic potential in human breast carcinoma cells.[8] Because of the potential toxicity, the 
U.S. EPA set a Reference Dose (RfD) of 0.25 mg/kg/day for both acute and chronic dietary 
exposures to permethrin.[9] The World Health Organization (WHO) has set a limit of 0.3 
mg/L (300 ng/mL) as a guideline for permethrin in drinking water when it is applied to 
water for mosquito control.[10] The Agency for Toxic Substances and Disease Registry 
(ATSDR) determined Minimum Risk Levels (MRLs) for oral exposures to technical grade 
permethrin of 0.3 mg/kg/day for acute oral exposures (up to 14 days) and 0.2 mg/kg/day for 
intermediate durations (15–364 days).[11]
After humans are exposed to pyrethroids, the parent compounds measured in plasma have a 
half life of 2.5–12 hr.[12,13] The parent compounds are hydrolyzed by an esterase enzyme to 
3-phenoxybenzyl alcohol or 3-phenoxybenzaldehyde. These compounds are rapidly 
converted to 3-phenoxybenzoic acid (3-PBA). The 3-PBA is conjugated to glucuronic acid 
that renders the xenobiotic more polar and facilitates its excretion in urine. In mammals, 
pyrethroid esters are mostly eliminated in urine (93%) during the first 24 hour.[14] Total 3-
phenoxybenzoic acid (3-PBA), has been measured in human urine as a biomarker of 
exposure.[15,16] Other metabolites such as cis- and trans-3-(2,2-dichlorovinyl)-2,2-
dimethylcyclopropane-1-carboxylic acid that derive from parent compounds such as 
cyfluthrin, permethrin, and cypermethrin [17] are also formed but were not measured in this 
study.
The disadvantage to measuring 3-PBA in the urine is that it is considered a biomarker of 
acute exposure, since the metabolite is so rapidly eliminated. On the other hand, it is well 
known that protein adducts of xenobiotics measured in plasma are persistent biomarkers 
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having half lives up to several months.[18] The compound 3-PBA-glucuronide has also been 
shown to form protein adducts.[19] Two mechanisms of adduct formation from 
glucuronidation of carboxylic acids have been demonstrated. In the transacylation 
mechanism, acyl glucuronides that are potentially electrophilic can react with nucleophilic 
residues in proteins. According to the glycation mechanism, an initial internal acyl migration 
occurs and also reacts with amino groups of the protein, leading to Schiff base adducts or 
Amadori rearrangement.[20] The most likely protein in humans for adduction of acyl 
glucuronides is albumin due to its abundance (60%) in blood.[21]
Analytical methods for the detection of pyrethroid metabolites such as high-performance 
liquid chromatography (HPLC) or gas chromatography (GC) with mass spectrometry (MS) 
are expensive.[14, 22–24] Enzyme-linked immunosorbent assays (ELISA) have been 
presented as a cost effective alternative to instrumental methods.[25] Because of the potential 
health implications, it is important to monitor populations in order to form strategies to 
minimize exposure. Thus, we opted to determine both plasma and urinary 3-PBA in 
populations consisting of consumers and farmers in Thailand utilizing an immunoassay to 
monitor 3-PBA in urine [26] that had been further adapted and validated to measure 3-PBA 
in plasma following hydrolysis of adducts.[27] To our knowledge this is the first study to 
assess 3-PBA protein adducts in humans.
Materials and methods
Materials and instrumentation
Bovine serum albumin (BSA), fetal bovine serum, goat anti-rabbit immunoglobulin G 
(whole molecule) peroxidase conjugate (GAR-HRP), H2O2, Tween 20, dimethyl sulfoxide, 
3,3′,5,5′-tetramethylbenzidine (TMB), N,N-dimethyl-formamide (DMF), N-
hydroxysuccinimide (NHS) and 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
hydrochloride (EDC) were obtained from Sigma-Aldrich (St. Louis, MO, USA). All other 
chemicals were reagent grade or better from Fisher Scientific (Pittsburgh, PA, USA) or 
Merck (Darmstadt, Germany). The samples were extracted using Strata Screen-A mixed 
mode solid phase extraction columns (8B-S019-EAK, Phenomenex, Torrance, CA, USA). 
The ELISA method was performed on Nunc Maxisorp Immunoplates (96F, 442404, 
Roskilde, Denmark) and read spectrophotometrically with a microplate reader (Tecan 
Sunrise, Männedorf, Switzerland). A creatinine kit (Sysmex Corporation, Kobe, Japan) was 
used to measure the concentration of creatinine in urine according to the manufacturer’s 
instructions.
Study site and population characteristics
The present study was a cross-sectional study designed to assess pyrethroid exposure among 
consumers and farmers. Farmer volunteers were assumed to be occupationally exposed. The 
Fang district of Chiang Mai province, one of the most intensive agricultural areas in 
northern Thailand, is composed of eight sub-districts. The four sub-districts with the most 
intensive agriculture were selected as study sites. These were Mae Kha, Mae Ngon, Wiang, 
and Mae Ka sub-districts. These four sub-districts contained 56% (63,879) of the total Fang 
district population (112,402).[28] The subjects included 100 consumers (50 females, 50 
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males) and 100 farmers (50 females, 50 males). Farmers and consumers in these selected 
sub-districts were sampled using a random number of their household numbers in order to 
provide the same probability of being selected into the study. Numbers of farmers and 
consumers participated in the study described by sub-district is shown in Table 1. This study 
was approved by the Human Experimentation Committee, Research Institute for Health 
Sciences (RIHES), Chiang Mai University (No. 32/2006).
Sample collection and preparation
A consent form was introduced and signed by individual participants prior to collection of 
personal data, blood, and urine samples. Blood and urine samples were taken in the morning 
of the same day. Approximately, 10 mL of venous blood samples in vacutainer heparinized 
tubes and 50 mL of midstream morning void urine samples in 250 mL polypropylene bottles 
were collected and placed in the ice chest. The samples were then transported to Toxicology 
Laboratory, Research Institute for Health Sciences, Chiang Mai University (about 150 km 
away). On the next day, blood samples were centrifuged at 2500 rpm for 15 min at 4°C to 
collect plasma. Plasma and urine samples were aliqouted into 1 mL and 10 mL, respectively, 
and then frozen (−20°C) until analysis. On the day of analysis, samples were thawed at room 
temperature, gently mixed to homogeneity and then sampled for analysis. The analyses of all 
samples were finished within 1 year.
The plasma 3-PBA [27] and urinary 3-PBA analyses [15,29] were modified from previous 
studies. To prepare plasma samples, briefly, 100 μL sodium hydroxide (6 N) was added to 
the plasma (0.5 mL) and placed in a heating block at 100°C for 1 hr to hydrolyze the 3-PBA 
adduct. After cooling, 1 mL of 0.2 M sodium acetate buffer, pH 4.5 was added to adjust the 
pH to around 12. For further cleanup, liquid-liquid extraction (LLE) was employed by 
adding 2 mL of ethyl acetate and the sample shaken vigorously for 10 min. The ethyl acetate 
was discarded. The ethyl acetate removes organic contaminants while the 3-PBA remains in 
the aqueous phase. To the remaining aqueous phase was added 120 μL of hydrochloric acid 
(6 N) to adjust the pH to around 3. This was extracted twice with 2 mL of ethyl acetate. The 
organic phases were evaporated to dryness under a gentle stream of nitrogen. The residue 
was dissolved in 200 μL of methanol. Two milliliters of 0.2 M sodium acetate buffer was 
added to adjust the pH to around 5 and mixed thoroughly. The sample was then ready for 
solid phase extraction (SPE). The SPE cartridge used was the Strata Screen-A (55 μm, 70 
Å), 100 mg/mL containing a mixed mode silica-based sorbent consisting of mixed-mode 
SPE hydrophobic (C8) and ionic (anion exchange) phases. The SPE method was described 
previously.[15]
For measurement of 3-PBA in urine, we used a common acid hydrolysis method to release 
any 3-PBA that may have been in the conjugated form such as glucuronides, sulfates or 
amino acids. A 0.5 mL aliquot of urine was added into a glass vial. The urine sample was 
treated with 100 μL of 6 N hydrochloric acid and heated at 100°C for 1 hr. The hydrolyzed 
urine was neutralized by adding 1 mL of 0.2 M sodium acetate buffer (pH 4.5) followed by 
100 μL of sodium hydroxide (6 N) and mixing thoroughly to adjust the pH to around 4.5. To 
reduce the matrix effect of the hydrolyzed urine, the same SPE method as for the plasma 3-
PBA was used.
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Sample analysis
The specific antibody and hapten for the target analyte (3-PBA) and the preparation of 
coating antigen, the buffers and the procedure for the indirect competitive ELISA was 
previously described.[29] Briefly, 96-well plates were coated overnight at 4°C with 100 μL 
of coating antigen, 3-PBA-BSA, (0.5 μg/mL). The following day, plates were blocked for 30 
min with 200 μL 0.5% BSA in PBS (phosphate buffered saline) at room temperature. After 
30 min the blocking solution was removed. Then 50 μL of extracted samples (plasma or 
urine) and 50 μL of antiserum (1:7000) were added to each well and mixed for 1 hr at room 
temperature. The plates were washed five times. The goat anti-rabbit IgG-horseradish 
peroxidase conjugate diluted 1/10000 (100 μL) was added for 1 hr. Following a wash, the 
TMB substrate (100 μL) was added for 15 min then the reaction stopped and absorbance 
measured at 450 nm. The concentrations of unknown samples were calculated from the 
calibration curve using a 4-parameter fit equation and expressed as 3-PBA equivalents. 
Urinary 3-PBA concentrations were normalized to creatinine levels to correct for dilution of 
urine and is often used to normalize when spot samples are taken rather than 24 hr 
samples.[30] Although plasma 3-PBA may be referred to as the 3-PBA-adduct, the 
concentrations reported here are a measure of the total of bound and free 3-PBA in the 
plasma.
Previous work from this laboratory described suitable conditions for the ELISA analysis of 
plasma 3-PBA.[27] An IC50 value of 26.7 ng/mL and reproducibility (%CV < 15%) was 
obtained. The IC50 value is expressed as the sensitivity of the immunoassay and 
approximates the concentration of analyte giving 50% inhibition. The recovery of spiked 
free 3-PBA in plasma was 85.9–99.4%. More than 80% 3-PBA was recovered from the 
adducted form (3-PBA-BSA) when subjected to hydrolysis. The limit of quantitation (LOQ) 
was 5 ng/mL, 30- to 40-fold more sensitive than a previous study (150–200 ng/mL) that 
used HPLC analysis.
Quality assurance and control
For laboratory quality assurance and control, precision measurements were conducted prior 
to the analysis of real samples. Plasma and urine controls (10 tubes) were analyzed for day-
to-day variation of samples to obtain an optimum condition variance (OCV) range (mean ± 
2SD). Each plasma analysis batch consisted of 15 samples, 1 sample blank and 2 controls 
using pooled plasma that were placed in the first and last tubes. For urine, 25 samples were 
analyzed in each batch with 3 pooled urine controls placed in the first, middle and last tubes. 
The controls in each batch were analyzed for intra-batch variation of samples to obtain 
within-day CV (%). Inter-batch variation of samples was analyzed from controls in all 
batches analyzed (n = 14 and 9, respectively) to obtain between-day CV (%).
Statistical analysis
Data from laboratory results were analyzed by SPSS Statistical Software Package (SPSS, 
Thailand) version 17 as follows; (1) the concentrations of 3-PBA were tested for normal 
distribution (parametric or nonparametric), (2) % detection, median and range of 3-PBA 
concentrations were computed, (3) the plasma 3-PBA and urinary 3-PBA concentrations 
were compared between consumers and farmers using the paired sample t-test, (4) the 
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correlation between plasma 3-PBA and urinary 3-PBA concentrations was analyzed using 
the Spearman test.
Results and discussion
Optimization of the ELISA method
The optimal conditions for the ELISA analysis of plasma 3-PBA was previously developed 
in this laboratory and described above.[27] The assay for 3-PBA in urine was also previously 
reported. The IC50 value in that study was reported at 1.65 ± 0.7 ng/mL.[29] In our hands, the 
optimized assay using antiserum 294 (diluted 1:7000, final dilution in well) and a coating 
antigen concentration of 0.5 μg/mL gave an IC50 value of 15.3 ± 0.77 ng/mL (Fig. 1). 
Although the IC50 was different, it was highly reproducible, so no further optimization was 
done. It is not unusual for there to be systematic differences in IC50 between laboratories. 
Minor differences between operations, preparation of calibrators, or reagent degradation are 
among some of the causes of such variations.[31]
Most immunoassays exhibit some cross reactivity to structurally related compounds. The 
assay used here does not cross react with a variety of parent pyrethroids (permethrin, 
cypermethrin, esfenvalerate, deltamethrin and cyfluthrin) that contain the phenoxybenzyl 
moiety. However, 4-fluoro-3-phenoxybenzoic acid, a metabolite of cyfluthrin does cross 
react at 72% [29] while 4-hydroxy-3-phenoxybenzoic acid and 3-phenoxybenzaldehyde cross 
react at 103 and 75%, respectively. Using the same methods as reported here, urine samples 
collected from forestry workers were analyzed by both LC/MS/MS and immunoassay for 3-
PBA. The methods correlated well with slope, intercept and r2 of 1.14, 0.24 and 0.964, 
respectively.[15] Thus, these other cross-reacting metabolites likely did not greatly impact 
the determination of urinary 3-PBA for that study population and were not considered 
significant in the study reported here.
Sample preparation
The 3-PBA immunoassay has been assessed for matrix effects from plasma. Recovery of a 
laboratory-generated 3-PBA-protein adduct (the 3-PBA was adducted to bovine serum 
albumin) spiked into fetal bovine serum were greater than 80%. In addition, we found that 
an additional LLE cleanup was necessary before SPE extraction to eliminate the matrix 
effect of plasma samples. This resulted in high recovery values (85.9–99.4%) with a limit of 
quantitation (LOQ) at 5 ng/mL.[27] In this study, for urinary 3-PBA, SPE extraction was 
necessary to determine 3-PBA metabolites. The SPE cleanup technique gave high recovery 
values (87.3–98.0%) with limit of quantitation at 2.5 ng/mL (Table 2), comparable to values 
obtained earlier.[15]
The limit of blank, limit of detection and limit of quantitation as defined by Armbruster and 
Pry[32] are shown in Table 3. The urine spiked with levels lower than the limit of 
quantitation were not detected (ND, Table 2) as expected. Analysis of 3-PBA spiked into 
fetal bovine serum at 4 ng/mL gave values nearly identical to 5 ng/mL.[27] This higher 
recovery in serum may be due to a matrix effect hence the LOQ was set to 5 ng/mL. 
Samples with concentrations lower than 5 and 2.5 ng/mL, in serum and urine respectively, 
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were not quantitated. The methods reported here are selective and sensitive enough to assess 
samples from both acute and chronic exposures to pyrethroids. For example the RfD for 
pyrethroids is 0.25 mg/kg/day.[9] Assuming an average person weighs 70 kg, has a blood 
volume of 5 L, and consumes, in a single day, 0.25 mg of pyrethroid and all was absorbed 
and circulating in the blood, then the expected concentration in the blood would be about 3.5 
μg/mL, well above the LOQs reported here.
Quality assurance and control
For quality control, pooled samples of plasma or urine were used. Two or three replicates of 
the pooled samples were run with each batch of samples. The coefficient of variation (% 
CV) was less than 5% for both plasma and urine. Moreover, all control concentrations were 
within the OCV range (mean ± 2SD; 5.79–6.83 and 14.8–17.8 ng/mL, respectively) as 
shown in Table 4.
Exposure study
From the questionnaire, data showed that the volunteers in this study used pesticides in the 
home and in agriculture practices. Of the total study population (consumers and farmers; n = 
200), 56% used pesticides indoors. The concentration of plasma 3-PBA in the volunteers 
who used indoor pesticides (n = 106) was significantly higher (P < 0.005) than who did not 
use them (n = 94). Twenty-five percent of the farmers (n = 100) applied pesticides 
agriculturally. The farmers (n = 100) used a variety of pesticide types: 83% insecticides 
including synthetic pyrethroids, 75% herbicides, 72% chemical fertilizers, 56% organic 
fertilizers and 41% plant growth substances.
The % detection of plasma 3-PBA was less than 50% overall while the detection of urinary 
3-PBA was greater than 50% for both groups (Table 5). Although the rates of detection in 
plasma or urine were similar between the groups, the range of urinary concentrations was 
generally higher for the farmer group and the median concentrations were significantly 
different a P < 0.01 likely reflecting recent acute exposures in the farmer group. Longer-
term exposure seems more similar between the groups since the median and range of plasma 
3-PBA concentration was similar between groups.
In Table 6, the % detection of plasma 3-PBA and urinary 3-PBA for consumer and farmer 
groups are broken out by concentration ranges. Plasma concentrations for all subjects were 
less than 10 ng/mL although the rate of detection was nearly double in farmers compared to 
consumers in the 5.1–10 ng/mL range. Similarly more farmers than consumers had urinary 
concentrations of 3-PBA greater than 10 μg/g creatinine and the upper range of 
concentrations were much higher for farmers. Additionally, the concentrations of urinary 3-
PBA in farmers in Chiang Mai at selected percentile values in the present study were higher 
than found by previous researchers (Fig. 2).[33,34] This may be due to different agricultural 
practices.
Thus, the farmer group appears to have greater acute exposure most likely due to their 
agricultural activities.[33] Consumers that lived in communities where crops were produced 
also likely had more potential for exposure to insecticides.[24] However, there are other 
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pathways and routes by which both farmers and consumers may be exposed to these 
insecticides. Consumption of pesticide-contaminated vegetables and fruits was thought to be 
the major route by which volunteers were exposed to pesticides. The other routes were 
dermal contact and the respiratory route from insecticide drift in the air from vector control 
programs [35] and from usage in the household for controlling insects.
Interestingly, there was no correlation between plasma 3-PBA and urinary 3-PBA 
concentrations in the study population. However, the farmer population likely had more 
recent acute exposures that would lead to transient high urinary 3-PBA concentrations. Also, 
metabolism and urinary elimination of pyrethroids varies by individual.[36] Further studies 
are necessary to determine the precise reasons for the difference.
Conclusion
A sensitive and specific ELISA for plasma and urinary 3-PBA had been developed. The 
modified methods were successfully applied to the detection of 3-PBA, a urinary metabolite 
of some pyrethroid insecticides among a rather large population in an agricultural area. 
These assays could analyze 20 and 37 samples per day for plasma and urine samples, 
respectively. The ELISA generated data rapidly (within 3 hr) and was suitable for routine 
analysis. We estimate that each sample cost about $12.00 to analyze, compared to the 
relatively high cost ($50–150 per sample) of instrumental analysis such as a liquid 
chromatography-tandem mass spectrometry (LC/MS/MS). To our knowledge, this is the 
first report that compares plasma 3-PBA, including the adducted form and urinary 3-PBA in 
a large group of volunteers. Although there was no correlation between plasma 3-PBA and 
urinary 3-PBA concentrations in the study population, it may be due to differences in 
metabolism and urinary elimination of pyrethroids among individual as well as the higher 
likelihood those farmers have recent acute exposures. Further studies will be needed to 
validate the 3-PBA in plasma as a biomarker of cumulative exposures to pyrethroids. 
However, the applications of the methods for plasma and urinary 3-PBA analyses in this 
study showed confirmation that these volunteers are exposed.
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Fig. 1. 
ELISA inhibition curve for urinary 3-PBA using antiserum 294 (diluted 1:7,000, final 
dilution in well), coating antigen 3-PBA-BSA (0.5 μg/mL), and GAR-HRP (1:10,000). IC50 
(15.3 ± 0.77 ng/mL) approximates the concentration of analyte giving 50% inhibition. The 
X axis is the log of the 3-PBA concentration and the Y axis is %B/B0 calculated from 
(absorbance of sample/absorbance of blank) × 100. The standard deviation was calculated in 
duplicate (n = 2) at each point.
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Fig. 2. 
The concentrations of urinary 3-PBA in farmers in Chiang Mai province at Mae Rim district 
(N = 40 [34]) and Mae Taeng District (N = 69 [33]) at selected percentile values compared to 
the present study (Fang district).
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Table 1
Participant distribution through 4 sub-districts in the Fang district of Chiang Mai, Thailand.
Subdistricts Consumer (n) Farmer (n)
Mae Kha 37 20
Mae Ngon 19 15
Wiang 26 36
Mae Ka 18 29
Total 100 100
Consumer and farmer groups consisted of 50 males and 50 females.
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Table 2
Recoveries after hydrolysis, extraction and ELISA analysis of 3-PBA spiked in urine containing no detectable 
3-PBA by ELISA, in triplicate (n = 3) on the same day.
Standard
addition(ng/mL)
Mean ± SD (n = 3)
of 3-PBA (ng/mL) % Recovery
1 ND ND
2.5 2.32 ± 0.20 92.8
5 4.47 ± 0.72 89.5
10 8.73 ± 0.16 87.3
20 19.6 ± 0.34 98.0
ND = Not detected, because the signal was not distinguishable from background.
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Table 3
Limit of blank (LOB), limit of detection (LOD) and limit of quantitation (LOQ) of methods for measurement 
of plasma 3-PBA and urinary 3-PBA.
Value
Plasma 3-PBA
Mean ± SD,
n = 2, (ng/mL)
Urinary 3-PBA
Mean ± SD, n = 2
(μg/g Creatinine)
LOB 0.50 ± 0.03 0.46 ± 0.01
LOD 1.08 ± 0.20 1.94 ± 0.34
LOQ 5.00 ± 0.19 2.50 ± 0.37
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Table 4
Intra- and inter-assay variation of pooled controls for plasma and urine.
Plasma 3-PBA Urinary 3-PBA
Concentration
(ng/mL) 2 tubes;intra-variation
% CV of controls
Concentration (ng/mL) 3 tubes;
intra-variation
% CV of controlsBatches First-tube Last-tube Batches First-tube Mid-tube Last-tube
1 5.95 5.95 0.01 1 17.3 16.4 17.2 2.88
2 6.22 6.49 3.03 2 15.6 15.2 16.2 2.95
3 6.12 5.82 3.52 3 16.5 16.1 15.8 2.13
4 6.47 6.47 0.00 4 16.1 15.7 16.8 3.58
5 6.22 6.27 0.57 5 15.9 15.7 16.9 4.08
6 6.66 6.27 4.34 6 16.1 16.4 15.7 1.90
7 6.37 6.37 0.01 7 17.3 16.4 17.2 2.88
8 6.50 6.47 0.38 8 15.6 15.2 16.2 2.95
9 6.29 6.48 2.21 9 16.5 16.1 15.8 2.13
10 6.30 6.24 0.74 % CV of controls (27 tubes; inter-variation) = 4.60
11 6.15 6.09 0.75
12 6.22 5.96 3.02
13 6.34 6.14 2.25
14 6.10 5.91 2.34
% CV of controls (28 tubes; inter-variation) = 4.14.
J Environ Sci Health B. Author manuscript; available in PMC 2015 January 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
THIPHOM et al. Page 17
Table 5
Descriptive analytical data for plasma 3-PBA and urinary 3-PBA detected in human plasma between 
consumers (n = 100) and farmers (n = 100).
% Detection Median Range
Metabolites Consumer Farmer Consumer Farmer Consumer Farmer
Plasma 3-PBA (ng/mL) 24 42 5.82 6.27 5.16–8.44 4.29–9.57
Urinary 3-PBA (μg/g creatinine) 76 69 8.86 16.1* 1.62–80.5 0.80–256.2
*Significantly different between groups at P < 0.01 using a paired T test.
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Table 6
The % detection of plasma 3-PBA and urinary 3-PBA in consumer and farmer groups by concentration 
ranges.
% Detection
Consumer (n = 100) Farmer (n = 100)
Concentration
ranges
plasma 3-PBA
(ng/mL)
urinary 3-PBA
( μ g/g creatinine)
plasma 3-PBA
(ng/mL)
urinary 3-PBA
( μ g/g creatinine)
Less than 2.5 76 27 59 36
2.5–5.0 (Less than 5) 15 (Less than 5) 10
5.1–10.0 24 26 42 11
10.1–20.0 – 10 – 12
20.1–30.0 – 7 – 6
30.1–40.0 – 5 – 6
40.1–50.0 – 3 – 6
More than 50 – 7 – 13
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